Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation

Key Points from the Announcement

• Completion of Major Corporate Actions: Quantum Healthcare Limited has announced the successful completion of its Proposed PW Debt Conversion and Proposed Directors’ Fees Capitalisation.
• Significant Increase in Share Capital: The company has allotted and issued a total of 1,846,129,636 new shares to both PW Dental and its directors, representing a substantial increase in the issued and paid-up share capital.
• New Share Allocation: The breakdown of newly issued shares is as follows:
  • PW Dental: 1,595,912,182 shares
  • Ng Fook Ai Victor: 87,878,545 shares
  • Melvin Lim Chun Siong: 26,909,091 shares
  • Ramasamy Jayapal: 7,272,727 shares
  • Ng Boon Eng: 70,000,000 shares
  • Sho Kian Hin: 58,157,091 shares
• Total Share Capital Now at 12.59 Billion Shares: Following these allotments, Quantum Healthcare’s total issued and paid-up share capital increased from 10,741,773,908 shares to 12,587,903,544 shares.
• Share Ranking and Rights: The new shares will rank pari passu in all respects with existing shares, except for dividends, rights, allotments, or other distributions declared before the date of their allotment and issuance.
• Listing of New Shares: The new shares are expected to be listed and quoted on the Catalist of the SGX-ST on or around 5 January 2026, effective from 9:00 a.m.
• Ownership Structure Update: PW Dental, a company wholly owned by Dr Gian Siong Lin Jimmy, will initially have its shares credited into Dr Jimmy’s CDP Securities Account, to be held as nominee and on trust for PW Dental, pending the opening of PW Dental’s corporate CDP account.

Important Details for Shareholders

• Substantial Dilution: The issuance of nearly 1.85 billion new shares represents a noteworthy dilution for existing shareholders. The total share base has increased by approximately 17%.
• Potential Price Sensitivity: The entry of such a large block of shares into the market may put downward pressure on the share price due to dilution and the possibility of subsequent selling by recipients.
• Strategic Debt Conversion: The conversion of debt into equity, particularly to PW Dental, could strengthen the company’s balance sheet, reduce leverage, and potentially position Quantum Healthcare for future growth or investments.
• Directors’ Alignment: The capitalisation of directors’ fees into shares aligns the interests of key management with those of shareholders, potentially incentivising performance and commitment.
• Dividend Exclusion: The new shares will not participate in any dividends or distributions declared before their issuance. Investors should note this exclusion for record-keeping and dividend expectations.
• Potential Changes in Control: The substantial shareholding by PW Dental may result in significant influence over Quantum Healthcare’s strategic direction and decisions.

What Investors Should Watch For

• Trading Activity: Monitor trading volumes and price movements as the new shares begin trading on the SGX-ST Catalist, especially on and after 5 January 2026.
• Corporate Strategy: Watch for further announcements regarding Quantum Healthcare’s growth strategy, possible acquisitions, or operational changes now that the debt conversion has strengthened the balance sheet.
• Shareholder Communications: Stay alert for updates on any changes in board composition, executive incentives, or other material developments following the capitalisation of directors’ fees.

Conclusion

The completion of Quantum Healthcare’s Proposed PW Debt Conversion and Directors’ Fees Capitalisation marks a pivotal moment for the company, significantly expanding its share base and realigning its capital structure. This transaction is highly material, with potential implications for share price due to dilution, changes in ownership influence, and the company’s future strategic direction. Investors are advised to monitor developments closely as the new shares begin trading and as the company leverages its stronger balance sheet.

Disclaimer: The above report is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with financial advisors before making any investment decisions. The information is based on company disclosures and may be subject to change or interpretation. No liability is accepted for any loss or damage arising from reliance on this report.

View Quantum Health Historical chart here